CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO
New Study Links Synthetic Cannabinoid Products to Strokes
A November 20, 2013, article on the website redOrbit highlighted the results of a University of Southern Florida (USF) study that discovered a link between smoking synthetic marijuana and stroke occurrence in healthy young adults. The results, published in the academic journal Neurology, focused on case studies of two siblings who had both experienced strokes shortly after smoking Spice, an herbal mixture containing potentially dangerous synthetic cannabinoids (Link Between Synthetic Marijuana And Stroke - Health News - redOrbit).
 
Prior to experiencing strokes, both siblings, a brother and a sister, smoked Spice containing the schedule I synthetic cannabinoid JWH-018. Brain imaging of the siblings showed blood vessel abnormalities consistent with reports of adverse cardiac events associated with Spice use, such as myocardial infarction and tachyarrhythmia.
 
Researchers ruled out any undiagnosed genetic conditions as potential causes of the strokes. “We rigorously looked for those [undiagnosed genetic conditions] and didn’t come up with anything,” commented Dr. Scott Burgin, senior author of the study and USF professor, and director of the Comprehensive Stroke Center at Tampa General Hospital.
 
The researchers suggested that an unknown toxin or contaminant may have induced the strokes both siblings experienced. According to Dr.Burgin, using synthetic cannabinoid products such as Spice and K2, pose greater health risks than using natural marijuana, because they often contain unknown, potentially dangerous adulterants. “You don’t know what you’re getting when you smoke synthetic marijuana… you may be playing dangerously with your brain and your health.”
 
Cerilliant offers certified Snap-N-Spike® solutions for numerous Spice cannabinoids from single-component standards and multi mixes containing HU-210, JWH-018, JWH-073, HU-211, JWH-200, JWH-250, JWH-019, JWH-081, JWH-122, AM2201, (±)-CP 47, 497 and its C8 homologue to hydroxy (both omega and omega-1) and carboxylic acid metabolites as well as stable-labeled internal standards. These certified reference solutions are suitable in LC/MS or GC/MS testing methods for applications in urine drug testing, clinical toxicology, pharmaceutical research, and forensic analysis.
 
Cerilliant reference standards are manufactured and certified to the highest industry standards including ISO Guide 34, ISO/IEC 17025, and ISO 13485. Each Certified Spiking Solution® is supported by a comprehensive Certificate of Analysis (COA) that provides all analytical data and uncertainty and traceability information to support regulatory requirements. Click on the link below to view our complete listing of Spice cannabinoid reference standards:
 


Return to Article List


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn